Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: Prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations

Journal of the American Academy of Dermatology

Volumn 60, Issue 4, 2009, Pages 615-625

  Kaminaka, Chikako ^a   Yamamoto, Yuki ^a   Yonei, Nozomi ^a   Kishioka, Akiko ^a   Kondo, Toshikazu ^a   Furukawa, Fukumi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

actinic keratosis; Bowen disease; cyclin A; phenol; squamous cell carcinoma; treatment; tumor thickness

Indexed keywords

PHENOL; PLACEBO;

ACTINIC KERATOSIS; ADULT; AGED; APOPTOSIS; ARTICLE; BOWEN DISEASE; CANCER RISK; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; MALE; PARAMETER; PATIENT SELECTION; PILOT STUDY; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BOWEN'S DISEASE; FEMALE; HUMANS; KERATOLYTIC AGENTS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHENOLS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 61849089841     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.11.907     Document Type: Article

References (60)

1. Ishihara K., Saida T., Otsuka F., and Yamazaki N. the Prognosis and Statistical Investigational Committee of the Japanese Cancer Society. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 13 (2008) 33-41
2. Furukawa F., and Yamamoto Y. Recent advances in chemical peeling in Japan. J Dermatol 33 (2006) 655-661
3. Rodney D. Cryosurgery: unapproved uses, dosages, or indication. Clin Dermatol 20 (2002) 563-570
4. Hurwitz D.J., Pincus L., and Kupper T.S. Imiquimod: a topically applied link between innate and acquired immunity. Arch Dermatol 139 (2003) 1347-1350
5. Brody H.J. Chemical peeling and resurfacing. 2nd ed. (1997), Mosby, St Louis p. 29-38
6. Yamamoto Y., Ohtani T., Uede K., Furukawa F., Yonei N., and Kaminaka C. Phenol and trichloroacetic acid peeling is a new tool as non-invasive therapy to the aged patients with skin cancer. [abstract]. J Invest Dermatol 121 (2003) 1205
7. Yamamoto Y., Uede K., Yonei N., Kaminaka C., and Furukawa F. Expression of tenascin and human β-1 integrin in the skin peeled with phenol or trichloroacetic acid. Aesthetic Dermatol 13 (2003) 17-24
8. Yamamoto Y., Uede K., Ueda M., and Furukawa F. Characterization of monoclonal anti-human skin basal cell antibody 3B 4-6 and its reactivity to the skin peeled with phenol or trichloracetic acid (TCA). Aesthetic Dermatol 12 (2002) 70-76
9. Yamamoto Y., Yonei N., Kaminaka C., Kishioka A., Uede K., and Furukawa F. Effects of phenol peeling on dermal endothelial cells. J Dermatol Sci 35 (2004) 158-161
10. Yamamoto Y., Uede K., Otani T., Kishioka A., Tanaka A., and Furukawa F. Different apoptotic patterns observed in tissues damaged by phenol and TCA peels. J Dermatol Sci 2 Suppl (2006) 75-81
11. Stuzin J.M. Phenol peeling and the history of phenol peeling. Clin Plast Surg 25 (1998) 1-19
12. Peters W. The chemical peel. Ann Plast Surg 26 (1991) 564-571
13. Truppman E.S., and Ellenby J.D. Major electrocardiographic changes during chemical peeling. Plast Reconstr Surg 63 (1979) 44-48
14. Glogau R.G. The risk of progression to invasive disease. J Am Acad Dermatol 42 (2000) 23-24
15. Collen J.P., Bickers D.R., and Moy R.L. Actinic keratoses. J Am Acad Dermatol 36 (1997) 650-653
16. Dodson J.M., DeSpain J., Hewett J.E., and Clark D.P. Malignant potential of actinic keratoses and the controversy over treatment: a patient-oriented perspective. Arch Dermatol 127 (1991) 1029-1031
17. Kao G.F. Carcinoma arising in Bowen's disease. Arch Dermatol 122 (1986) 1124
18. Janine G.E., David S.A., James A.W., Paul B., Jenny B., and Thomas M.G. Relationship of p53 mutations and epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1 (1999) 468-475
19. Yam C.H., Fung T.K., and Poon R.Y.C. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59 (2002) 1317-1326
20. Bury J., and Cross S. Molecular biology in diagnostic histopathology: part I-the cell cycle. Curr Diagn Pathol 9 (2003) 266-275
21. Sandal T. Molecular aspects of mammalian cell cycle and cancer. Oncologist 7 (2002) 73-81
22. Brabo R., and Macdonald-Brabo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105 (1987) 1549-1554
23. Saeef T.R., Maruno M., Noor M.K., Mohammed A.K.K., Takamiyagi A., Uezato H., et al. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes. J Dermatol 29 (2002) 562-572
24. Tsuji T., Kitajima S., and Koashi Y. Expression of proliferating cell nuclear antigen (PCNA) and apoptosis related antigen (Ley) in epithelial skin tumors. Am J Dermatopathol 20 (1998) 164-169
25. Makino T., Tatebe S., Goto A., Mihara M., and Ito H. Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia. J Cutan Pathol 25 (1998) 136-142
26. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119 (1992) 493-501
27. Lack W., Lang S., and Brand G. Necrotizing effect of phenol on normal tissue and on tumors. Acta Orthop Scand 65 (1994) 351-354
28. Bukholm I.R.K., Bukholm G., Holm R., and Nesland J.M. Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas. J Clin Pathol 56 (2003) 368-373
29. Kuhling H., Alm P., Olsson H., Ferno M., Baldetorp B., Parwaresch R., et al. Expression of cyclin E, A and B, and prognosis in lymph node-negative breast cancer. J Pathol 199 (2003) 424-431
30. Saarilahti K., Kajanti M., Kouri M., Aaltonen L.M., Franssila K., and Joensuu H. Cyclin A and Ki 67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 986-995
31. Volm M., Koomagi R., Mattern J., and Efferth T. Expression profile of genes in non-small cell lung carcinomas from long term surviving patients. Clin Cancer Res 8 (2002) 1843-1848
32. Dobashi Y., Jiang S.X., Shoji M., Morinaga S., and Kameva T. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas. J Pathol 199 (2003) 208-220
33. Chen H.M., Kuo M.Y.P., Lin K.H., Lin C.Y., and Chiang C.P. Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol 39 (2003) 476-482
34. Nozoe T., Korenaga D., Futatsugi M., Saeki H., Ohga T., and Sugimachi K. Cyclin A expression in superficial squamous carcinoma of esophagus and coexisiting infiltrated lymphocyte follicle. Cancer Lett 188 (2002) 221-229
35. Handa K., Yamakawa M., Takeda H., Kimura S., and Takahashi T. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer 84 (1999) 225-233
36. Scott I.S., Morris L.S., Bird K., Davies R.J., Vowler S.L., Rushbrook S.M., et al. A novel immunohistochemical method to estimate cell cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer. J Pathol 201 (2003) 187-197
37. van de Putte G., Kristensen G.B., Lie A.K., Baekelandt M., and Holm R. Cyclins and proliferation markers in early squamous cervical carcinoma. Gynecol Oncol 92 (2004) 40-46
38. Kyushima N., Watanabe J., Hata H., Jobo T., Kameva T., and Kuramoto H. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 128 (2002) 307-312
39. Shih N.C., Shiozawa T., Kato K., Imai T., Miyamoto T., Uchikawa J., et al. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 34 (2003) 471-478
40. Ito Y., Yoshida H., Nakano K., Takamura Y., Kobayashi K., Yokozawa T., et al. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation. Pathol Res Pract 198 (2002) 397-402
41. Florenes V.A., Maelandsmo G.M., Faye R., Nesland J.M., and Holm R. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol 195 (2001) 530-536
42. Georgieva J., Sinha P., and Schadendorf D. Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions. J Clin Pathol 54 (2001) 229-235
43. Tran T.A., Ross J.S., Carlson J.A., and Mihm M.C. Mitotic cyclins and cyclin-dependent kinases in human benign and malignant melanocytic lesions. Hum Pathol 29 (1998) 1085-1090
44. Koljonen V., Tukiainen E., Haglund C., and Bohling T. Expression of cyclin A in Merkel cell carcinoma. APMIS 112 (2004) 39-44
45. Brasanac D., Boricic I., Todorovic V., Tomanovic N., and Radojevic S. Cyclin A and b-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Br J Dermatol 153 (2005) 1166-1175
46. Nelson M.A., Einspar J.G., Alberts D.S., Balfour C.A., Wvmer J.A., Welch K.L., et al. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85 (1994) 23-29
47. Moles J.P., Moyret C., Guillot B., Jeanteur P., Guilhou J.J., Basset-Seguin N., et al. p53 gene mutations in human epithelial skin cancers. Oncogene 8 (1993) 583-588
48. Stephenson T.J., Royds J., Silcocks P.B., and MacDonald D.M. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol 127 (1992) 566-570
49. McGregor J.M., Yu C.C.-W., Dublin E.A., Levison D.A., and MacDonald D.M. Aberrant expression of p53 tumor-suppressor protein in non-melanoma skin cancer. Br J Dermatol 127 (1992) 463-469
50. Ro Y.S., Cooper P.N., Lee J.A., Quinn A.G., Harrison D., Lane D., et al. p53 Protein expression in benign and malignant skin tumors. Br J Dermatol 128 (1993) 237-241
51. Urano Y., Oura H., Sakaki A., Nagae H., Matsumoto K., Fukuhara K., et al. Immunohistochemical analysis of p53 expression in human skin tumors. J Dermatol Sci 4 (1992) 69-75
52. Nagano T., Ueda M., and Ichihashi M. Expression of p53 protein in an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol 129 (1993) 1157-1161
53. Sim C.S., Slater S.D., and McKee P.H. Mutant p53 protein is expressed in Bowen's disease. Am J Dermatol 14 (1992) 195-199
54. Gusterson B.A., Anbazhagan R., Warren W., Midgelv C., Lane D.P., O'Hare M., et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6 (1991) 1785-1789
55. Ren Z.-P., Hedrum A., Ponten F., Nister M., Ahmadian A., Lundeberg J., et al. Human epithelial cancer and accompanying precursors have identical p53 mutations different from p53 mutations in sun-damaged areas of clonally expanded non-neoplastic keratinocytes. Oncogene 10 (1995) 1053-1059
56. Dainichi T., Koga T., Furue M., and Isoda M. Paradoxical effect of trichloroacetic acid (TCA) on ultraviolet B-induced skin tumor formation. J Dermatol Sci 31 (2003) 229-231
57. Yamamoto Y., Uede K., Yonei N., and Furukawa F. Expression patterns of proliferating cell nuclear antigen in trichloroacetic acid peeled skin. J Dermatol 34 (2007) 95-98
58. Fitzpatrick R.E., Tope W.D., Goldman M.P., and Satur N.M. Pulsed carbon dioxide laser, trichloroacetic acid, Baker-Gordon phenol, and dermabrasion: a comparative clinical and histologic study of cutaneous resurfacing in porcine model. Arch Dermatol 32 (1996) 469-471
59. Kligman A.M., Baker T.J., and Gordon H.L. Long-term histologic follow-up of phenol face peels. Plast Reconstr Surg 75 (1985) 652-659
60. Kaminaka C., Yamamoto Y., and Furukawa F. Nevoid basal cell carcinoma syndrome successfully treated with trichloroacetic acid and phenol peeling. J Dermatol 34 (2007) 841-843